Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
4 Pricing and affordability are not side details GLP-1 analytics is inseparable from affordability
Zhang T, Li P, Wu X, et al
For those who want the widest selection of GLP-1 medications from a single provider, Mochi Health delivers
Phase 3 Outlook: Based on Phase 2 results, a Phase 3 trial is planned for the first half of 2025 to evaluate the co-formulated bremelanotide plus PDE5 inhibitor combination in PDE5i non-responders
No enhanced Contraindications information available for this drug
PlexusDx providers screen for contraindications during your initial consultation and monitor your response through follow-up assessments
US$ 25.12
US$ 29.69
US$ 29.08
US$ 23.56
US$ 23.79
US$ 23.45
US$ 22.78
US$ 27.67
US$ 23.50
US$ 23.12
US$ 23.17
US$ 29.19
